Bisaro Paul

SEC Form 4 insider trading activity

Bisaro Paul has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including MYGN, ZTS, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.

On the most recent filing, Bisaro Paul is listed as Director at MYRIAD GENETICS INC. Inside the rolling window, Bisaro Paul reported 2 open-market purchases totaling $179K in MYGN and ZTS and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,000 ZTS shares on May 13, 2026, worth $152K.

Companies traded

Other insiders at MYGN

Insider Buying

$179K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
MYGN
Bisaro Paul
Purchase$28KMay 14SEC ↗
ZTS
Bisaro Paul
Purchase$152KMay 13SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Bisaro Paul made?

Bisaro Paul has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including MYGN, ZTS since 2026.

Which companies does Bisaro Paul trade?

Bisaro Paul has filed SEC Form 4 disclosures for 2 companies, including MYGN, ZTS.

When was Bisaro Paul's most recent SEC Form 4 filing?

Bisaro Paul's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.

What is Bisaro Paul's total buy and sell value in the current window?

Inside the rolling retention window, Bisaro Paul bought $179K and sold $0 based on SEC Form 4 filings.

What was Bisaro Paul's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,000 ZTS shares on 2026-05-13, worth $152K, per SEC Form 4 filings.